ENTITY

Grace Therapeutics (GRCE US)

9
Analysis
Health Care • United States
Grace Therapeutics, Inc. operates as a late-stage biopharma company. The Company focuses on drug delivery and technologies addressing rare and orphan diseases. Grace Therapeutics serves clients in Canada and the United States.
more
•19 May 2026 08:11•Syndicated

Stock Trade Compilation Episode Siete

Presidio Production (now trading as FTW) came public via the EQV Ventures SPAC and immediately sketched out a playbook of acquiring low-decline PDP...

bullish•Grace Therapeutics
•10 Oct 2024 10:55•Syndicated

Acasti Pharma Inc (ACST) - Wednesday, Jul 10, 2024

Acasti Pharma is making progress in developing IV nimodipine for acute subarachnoid hemorrhages. Lead asset GTX-104 is the primary focus of their...

Share
x